+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biopharmaceuticals Market Research Reports

Plasma Protein Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Plasma Protein Therapeutics - Global Strategic Business Report

  • Report
  • October 2026
  • 183 Pages
  • Global
From
COVID-19 Vaccines - Global Strategic Business Report - Product Thumbnail Image

COVID-19 Vaccines - Global Strategic Business Report

  • Report
  • October 2026
  • 762 Pages
  • Global
From
From
mRNA Platform - Global Strategic Business Report - Product Thumbnail Image

mRNA Platform - Global Strategic Business Report

  • Report
  • October 2026
  • 164 Pages
  • Global
From
From
Biologics - Global Strategic Business Report - Product Thumbnail Image

Biologics - Global Strategic Business Report

  • Report
  • October 2026
  • 495 Pages
  • Global
From
Meningococcal Vaccines - Global Strategic Business Report - Product Thumbnail Image

Meningococcal Vaccines - Global Strategic Business Report

  • Report
  • October 2026
  • 142 Pages
  • Global
From
Biologics Safety Testing - Global Strategic Business Report - Product Thumbnail Image

Biologics Safety Testing - Global Strategic Business Report

  • Report
  • October 2026
  • 182 Pages
  • Global
From
From
Vaccine Adjuvants - Global Strategic Business Report - Product Thumbnail Image

Vaccine Adjuvants - Global Strategic Business Report

  • Report
  • October 2026
  • 191 Pages
  • Global
From
Pediatric Drugs and Vaccines - Global Strategic Business Report - Product Thumbnail Image

Pediatric Drugs and Vaccines - Global Strategic Business Report

  • Report
  • October 2026
  • 292 Pages
  • Global
From
Regenerative Medicine - Global Strategic Business Report - Product Thumbnail Image

Regenerative Medicine - Global Strategic Business Report

  • Report
  • October 2026
  • 198 Pages
  • Global
From
Tetanus Toxoid Vaccine - Global Strategic Business Report - Product Thumbnail Image

Tetanus Toxoid Vaccine - Global Strategic Business Report

  • Report
  • October 2026
  • 265 Pages
  • Global
From
Vaccine Delivery Devices - Global Strategic Business Report - Product Thumbnail Image

Vaccine Delivery Devices - Global Strategic Business Report

  • Report
  • October 2026
  • 282 Pages
  • Global
From
Spine Biologics - Global Strategic Business Report - Product Thumbnail Image

Spine Biologics - Global Strategic Business Report

  • Report
  • October 2026
  • 382 Pages
  • Global
From
From
Shingles Vaccines - Global Strategic Business Report - Product Thumbnail Image

Shingles Vaccines - Global Strategic Business Report

  • Report
  • October 2026
  • 269 Pages
  • Global
From
Biobetters - Global Strategic Business Report - Product Thumbnail Image

Biobetters - Global Strategic Business Report

  • Report
  • October 2026
  • 488 Pages
  • Global
From
Ruminant Vaccines - Global Strategic Business Report - Product Thumbnail Image

Ruminant Vaccines - Global Strategic Business Report

  • Report
  • October 2026
  • 563 Pages
  • Global
From
Peptide Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Peptide Therapeutics - Global Strategic Business Report

  • Report
  • October 2026
  • 486 Pages
  • Global
From
Loading Indicator

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders. Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively. Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more